Analystreport

Ultragenyx Pharmaceutical (RARE) was downgraded by Weiss Ratings from "sell (d-)" to "sell (e+)".

Ultragenyx Pharmaceutical Inc.  (RARE) 
Last ultragenyx pharmaceutical inc. earnings: 2/13 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.ultragenyx.com/investor-relations